These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5042021)
21. Pharmaceutical marketing: new rules for an old game. Zellmer WA Am J Hosp Pharm; 1979 May; 36(5):603. PubMed ID: 453212 [No Abstract] [Full Text] [Related]
22. A note on milligram potency and misleading promotion. Med Lett Drugs Ther; 1965 Mar; 7(6):24. PubMed ID: 5831355 [No Abstract] [Full Text] [Related]
23. [Doctors as naive (innocent) drug advertisers]. Shoenfeld Y Harefuah; 2008 Feb; 147(2):98-9. PubMed ID: 18357661 [No Abstract] [Full Text] [Related]
24. Drug advertisements. Daniels WL N Z Med J; 1971 Nov; 74(474):345. PubMed ID: 5289767 [No Abstract] [Full Text] [Related]
25. [Resisting drug propaganda]. Kalsbeek F Pharm Weekbl; 1973 Jan; 108(4):73-9. PubMed ID: 4685029 [No Abstract] [Full Text] [Related]
26. [An analysis of drug advertising in non-specialty medical journals]. López Valpuesta FJ; Hevia Alonso A; Vázquez Díaz JA; Fernández López JA; Fernández Alonso A Rev Clin Esp; 1993 Feb; 192(3):130-3. PubMed ID: 8465049 [TBL] [Abstract][Full Text] [Related]
27. Sources of drug information. Albert BL N Engl J Med; 1969 Jan; 280(5):274. PubMed ID: 5762172 [No Abstract] [Full Text] [Related]
28. Code of fair practices in the promotion of drug products. Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133 [No Abstract] [Full Text] [Related]
29. ASHP policy on the acceptance of advertising. Am J Hosp Pharm; 1992 Jan; 49(1):160-1. PubMed ID: 1442809 [No Abstract] [Full Text] [Related]
30. Drug ads. Some mislead consumers. Roberts SS Diabetes Forecast; 2003 Oct; 56(10):46-8. PubMed ID: 15317096 [No Abstract] [Full Text] [Related]
31. DTC drug ads in the spotlight. Guglielmo WJ Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630 [No Abstract] [Full Text] [Related]
32. Views of Louisiana pharmacists on advertisement of prescription drugs. Iyriboz Y J La State Med Soc; 1987 Jun; 139(6):47-9. PubMed ID: 3612112 [No Abstract] [Full Text] [Related]
33. [About medicines. Production, advertising, abuse and side effects of our drugs]. Spegg H Dtsch Krankenpflegez; 1974 Jun; 27(6):290-7. PubMed ID: 4495221 [No Abstract] [Full Text] [Related]
34. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
35. The effectiveness of pharmaceutical promotion to hospital pharmacists. Demeritt GA Am J Hosp Pharm; 1966 Jan; 23(1):13-23. PubMed ID: 5901349 [No Abstract] [Full Text] [Related]
36. "New products parade". N Engl J Med; 1969 May; 280(19):1074-5. PubMed ID: 5778417 [No Abstract] [Full Text] [Related]
37. [The industrial pharmacist in Quebec]. Marsan JP Union Med Can; 1980 Jan; 109(1):119-28. PubMed ID: 7385450 [No Abstract] [Full Text] [Related]
38. O-t-c advertising--benefit or detriment? Thain GJ; Bickart DO J Am Pharm Assoc; 1972 Oct; 12(10):508-10 passim. PubMed ID: 5069352 [No Abstract] [Full Text] [Related]
39. Current standards in reported drug trials. Reiffenstein RJ; Schiltroth AJ; Todd DM Can Med Assoc J; 1968 Dec; 99(23):1134-5. PubMed ID: 4881692 [No Abstract] [Full Text] [Related]
40. The use of generic or patent medicines in the Netherlands. Gebhardt DO J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]